018311346

---

September 21, 2020

Trademark Summary

The trademark application was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 13, 2020, and it was registered by office on January 20, 2021 without any oppositions.

The application was filed in English (Spanish was selected as the second language).

---

Goods And Services

• The mark was filed in class 42 with Scientific research in the field of genetics, genetic engineering, genetic sequencing, disease modeling, pharmacogenomics, and precision medicine.